Abstract
Schistosomiasis, a neglected tropical disease, is caused by the blood fluke that resides in the blood vessels in the human hosts. It presents as an acute, but mostly chronic, illness and is commonly found in the least developed countries with poor healthcare systems. Forty countries in Africa were endemic for schistosomiasis in sub-Saharan Africa (SSA) in 2010. Of the five species, Schistosoma haematobium, S. mansoni, S. japonicum, S. intercalatum and S. mekongi, that can infect humans, it is S. haematobium which causes urogenital schistosomiasis and S. mansoni and S. japonicum which cause intestinal schistosomiasis, which have public health importance, being responsible for most of the disease in SSA. Children, women and farmers in rural communities who depend on water contact for recreational, domestic or occupational activities are most vulnerable to the infection. Cross-border movements from unstable and conflict zones in SSA have contributed to the spread of the disease to previously non-endemic foci, and emigration from rural areas into the cities for economic opportunities has introduced the disease into some urban areas. Schistosomiasis causes around 4.5 million DALYs annually, with around 90 % of the burden of disease concentrated in SSA. Annual loss from disability due to schistosomiasis in Africa was estimated to be nearly half a billion US dollars approximately 70 % of the global cost. The life cycle involves an intermediate planorbid freshwater snail hosts – Bulinus truncatus and Biomphalaria pfeifferi – in the transmission of the infection with sexual and asexual stages. Man is the definitive host. Pathology and clinical morbidity of schistosomiasis are caused by eggs trapped in tissues and symptoms and signs of the disease present among other things, as haematuria in urinary schistosomiasis and abdominal pain, diarrhoea which can be bloody and blood in stool in intestinal schistosomiasis. Long-term complications from schistosomiasis include urinary tract infections, bladder calcification, hydronephrosis/hydroureter, kidney failure, lesions of the liver, portal vein, and spleen, leading to periportal fibrosis, hepatomegaly, splenomegaly, pipe-stem portal fibrosis, ascites, nodules in the vulva and bladder cancer. Microscopic examination for parasite eggs in the urine or stool is considered definitive for the diagnosis of the infection. Control of schistosomiasis is by transmission and morbidity control using health education, safe water supply, mollusciding, environmental management, chemotherapy praziquantel (PZQ) as drug of choice or combination of these measures. Whether or not schistosomiasis can only be controlled or can be eliminated using the current MDA with anthelminthes is an ongoing debate.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aldridge WN, Holmstedt B (1981) Metrifonate and dichlorvos: theoretical and practical aspects. History and scope of the conference. Acta Pharmacol Toxicol (Copenh) 49(Suppl 5):3–6
Allan RW (2001) The Johns Hopkins Hospital, Department of pathology. Johns Hopkins Microbiol Newsl 20:30
Anderson RM, May RM (1992) Infectious diseases of humans: dynamics and control. Oxford University Press, Oxford
Andersson KL, Chung RT (2007) Hepatic schistosomiasis: current treatment options. Gastroenterology 10(6):504–512
Arean VM (1956) Lesions caused by Schistosoma mansoni in the genitourinary tract of men. Am J Clin Pathol 26(9):1010–1021
Asaolu SO, Ofoezie IE (2003) The role of health education and sanitation in the control of helminth infections. Acta Trop 86(2–3):283–294
Awasthi S, Bundy DAP, Savioli L (2003) Helminthic infections. BMJ 327:431–433
Barakat R, Elmorshedy H, Fenwick A (2005) Efficacy of myrrh in the treatment of human schistosomiasis mansoni. Am J Trop Med Hyg 73(2):365–367
Batzinger RP, Bueding E (1977) Mutagenic activities in vitro and in vivo of five antischistosomal compounds. J Pharmacol Exp Ther 200(1):1–9
Beck L, Favre TC, Pieri OS, Zani LC, Domas GG, Barbosa CS (2001) Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up. Mem Inst Oswaldo Cruz 96(Suppl):165–167
Bergquist R, Utzinger J, McManus DP (2008) Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis 2(6):e244
Bierman WF, Wetsteyn JC, van Gool T (2005) Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med 12(1):9–13
Bogoch II, Andrews JR, Dadzie ERK, Utzinger J (2012) Simple questionnaire and urine reagent strips compared to microscopy for the diagnosis of Schistosoma haematobium in a community in northern Ghana. Trop Med Int Health 17(10):1217–1221
Bosompem KM, Ayi I, Anyan WK, Nkrumah FK, Kojima S (1996) Limited field evaluation of a rapid monoclonal antibody-based dipstick assay for urinary schistosomiasis. Hybridoma 15:443–447
Bosompem KM, Owusu O, Okanla EO, Kojima S (2004a) Applicability of a monoclonal antibody-based dipstick in diagnosis of urinary schistosomiasis in the Central Region of Ghana. Trop Med Int Health 9(9):991–996
Bosompem KM, Bentum IA, Otchere J, Anyan WK, Brown CA et al (2004b) Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health 9(8):917–922
Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M et al (2005) Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg 72(2):119–123
Brouwer KC, Ndhlovu PD, Wagatsuma Y, Munatsi A, Shiff CJ (2003) Epidemiological assessment of Schistosoma haematobium-induced kidney and bladder pathology in rural Zimbabwe. Acta Trop 85(3):339–347
Bruun B, Aagaard-Hansen J, Watts S (2008) The social context of schistosomiasis and its control. An introduction and annotated bibliography. Special Programme for Research & Training in Tropical Diseases (TDR) sponsored by UNICEF/UNDP/World Bank/WHO
Bueding E, Batzinger R, Petterson G (1976) Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C9333-Go/CGP 4540). Experientia 32(5):604–606
Camara A (1959) Female genital schistosomiasis. Rev Ginecol Obstet (Sao Paulo) 105:271–280
Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R, Sippel JE (1978) Schistosoma mansoni and S. haematobium infections in Egypt. III. Extrahepatic pathology. Am J Trop Med Hyg 27(1 Pt 1):55–75
Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41–51
Chu KY (1978) Trials of ecological and chemical measures for the control of Schistosoma haematobium transmission in a Volta Lake village. Bull World Health Organ 56(2):313–322
Cioli D, Pica-Mattoccia L, Archer S (1995) Antischistosomal drugs: past, present … and future? Pharmacology 68:35–85
Cioli D (2000) Praziquantel: is there real resistance and are there alternatives? Curr Opin Infect Dis 13(6):659–663
Cioli D, Pica-Mattoccia L (2003) Praziquantel. Parasitol Res 90(Supp 1):S3–S9
Cnops L, Tannich E, Polman K, Clerinx J, Van Esbroeck M (2012) Schistosoma real-time PCR as diagnostic tool for international travellers and migrants. Trop Med Int Health 17(10):1208–1216
Coulibaly JT, Knopp S, N’Guessan NA, Silué KD, Fürst T et al (2011) Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d’Ivoire. PLoS Negl Trop Dis 5(11):e1384. doi:10.1371/journal.pntd.0001384
Cringoli G, Rinaldi L, Albonico M, Bergquist R, Utzinger J (2013) Geospatial (s)tools: integration of advanced epidemiological sampling and novel diagnostics. Geospatial Health 7(2):399–404
Danso-Appiah A, De Vlas SJ (2002) Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18(3):125–129
Danso-Appiah A, De Vlas SJ, Bosompem KM, Habbema JD (2004) Determinants of health-seeking behaviour for schistosomiasis-related symptoms in the context of integrating schistosomiasis control within the regular health services in Ghana. Trop Med Int Health 9(7):784–794
Danso-Appiah A, Utzinger J, Liu J, Olliaro P (2008) Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev 16(3):CD000053. doi:10.1002/14651858.CD000053.pub2
Danso-Appiah A (2009) Treatment effects and integrated morbidity control of schistosomiasis. Ipskamp Publishers, Enschede 1–202
Danso-Appiah A, Stolk WA, Bosompem KM, Otchere J, Looman CW et al (2010) Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in Ghana. PLoS Negl Trop Dis 4(11):e867. doi:10.1371/journal.pntd.0000867
Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J (2013) Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev 2:CD000528. doi:10.1002/14651858.CD000528.pub2
Danso-Appiah et al (2014) Systematic review and meta-analysis of the circulating cathodic antigen (CCA) test in the diagnosis of schistosome infection (Submitted)
Davis A (2009) Schistosomiasis In: Cook GC, Zumla AI (eds) Manson’s tropical diseases, Section 11, Chapter 82, 22nd edn. Saunders Elsevier, pp 1431–1469. International edition. Printed in China
del Villar PL, Burguillo FJ, López-Abán J, Muro A (2012) Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS ONE 7(9):e45867. doi:10.1371/journal.pone.0045867
Doenhoff MJ (1998) Is Schistosomicidal chemotherapy sub-curative? Implications for drug resistance. Parasitol Today 14(10):434–435
Engels D, Savioli L (2006) Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol 22(8):363–366
Engels D, Chitsulo L, Montresor A, Savioli L (2002) The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82(2):139–146
Enk MJ, Silva OG, Rodrigues NB (2012) Diagnostic accuracy and applicability of a PCR system for the detection of Schistosoma mansoni DNA in human urine samples from an endemic area. PLoS ONE 7(6):e38947. doi:10.1371/journal.pone.0038947
Esrey SA, Potash JB, Roberts L, Shiff C (1991) Effects of improved water supply and sanitation on ascariasis, diarrhoea, dracunculiasis, hookworm infection, schistosomiasis, and trachoma. Bull World Health Organ 69(5):609–621
Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Diminished susceptibility to praziquantel in a Senegalese isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61–62
Feldmeier H, Chitsulo L (1999) Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection. Arzneimittelforschung 49(7):557–565
Feldmeier H, Doehring E (1987) Clinical experience with metrifonate. Review with emphasis on its use in endemic areas. Acta Trop 44(3):357–368
Fenwick A, Rollinson D, Southgate V (2006) Implementation of human schistosomiasis control: challenges and prospects. Adv Parasitol 61:567–622
Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM et al (2009) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008. Parasitology 136(13):1719–1730
Foster R (1987) A review of clinical experience with oxamniquine. Trans R Soc Trop Med Hyg 81(1):55–59
Garba A, Touré S, Dembelé R, Boisier P, Tohon Z et al (2009) Present and future schistosomiasis control activities with support from the Schistosomiasis Control Initiative in West Africa. Parasitology 136(13):1731–1737
Geerts S, Gryseels B (2001) Anthelmintic resistance in human helminths: a review. Trop Med Int Health 6(11):915–921
Glinz D, Silué KD, Knopp S, Lohourignon LK, Yao KP et al (2010) Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl Trop Dis 4(7):e754. doi:10.1371/journal.pntd.0000754
Grobusch MP, Mühlberger N, Jelinek T, Bisoffi Z, Corachán M et al (2003) Imported Schistosomiasis in Europe: sentinel surveillance data from Trop Net Europe. J Travel Med 10(3):164–169
Gryseels B, Polderman AM (1987) The morbidity of schistosomiasis mansoni in Maniema (Zaire). Trans R Soc Trop Med Hyg 81(2):202–209
Gryseels B, Polderman AM, Engels D (1992) Experiences with the control of schistosomiasis mansoni in two foci in central Africa. Mem Inst Oswaldo Cruz 87(Suppl 4):187–194
Gryseels B, Nkulikyinka L, Engels D (1994) Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni. Am J Trop Med Hyg 51:634–641
Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guissé F et al (2001) Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6(11):864–873
Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368(9541):1106–1118
Guo JG, Cao CL, Hu GH, Lin H, Li D, Zhu R, Xu J (2005) The role of ‘passive chemotherapy’ plus health education for schistosomiasis control in China during maintenance and consolidation phase. Acta Trop 96(2–3):177–183
Hatz CF (2001) The use of ultrasound in schistosomiasis. Adv Parasitol 48:225–284
Hatz CF (2005) Schistosomiasis: an underestimated problem in industrialized countries? J Travel Med 12(1):1–2
Helleberg M, Thybo S (2010) High rate of failure in treatment of imported schistosomiasis. J Travel Med 17(2):94–99
Hoffmann KF, Dunne DW (2003) Characterization of the Schistosoma transcriptome opens up the world of helminth genomics. Genome Biol 5:203
Hotez PJ (2009) Mass drug administration and integrated control for the world’s high-prevalence neglected tropical diseases. Clin Pharmacol Ther 85:659–664
Hotez P (2011) Enlarging the “Audacious Goal”: elimination of the world’s high prevalence neglected tropical diseases. Vaccine 29(Suppl 4):D104–D110. doi:10.1016/j.vaccine.2011.06.024
Hotez PJ, Pecoul B (2010) “Manifesto” for advancing the control and elimination of neglected tropical diseases. PLoS Negl Trop Dis 4(5):e718. doi:10.1371/journal.pntd.0000718
Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 3:e102
Hotez P, Raff S, Fenwick A, Richards F Jr, Molyneux DH (2007) Recent progress in integrated neglected tropical disease control. Trends Parasitol 23(11):511–514
Hotez PJ, Fenwick A, Savioli L, Molyneux DH (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373:1570–1575
Istre GR, Fontaine RE, Tarr J, Hopkins RS (1984) Acute schistosomiasis among Americans rafting the Omo River Ethiopia. JAMA 251:508–510
Johansen MV, Sacko M, Vennervald BJ, Kabatereine NB (2007) Leave children untreated and sustain inequity! Trends Parasitol 23(12):568–569
Jordan P (2000) From katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia. Acta Trop 77(1):9–40
Jordan P, Unrau GO, Bartholomew RK, Cook JA, Grist E (1982) Value of individual household water supplies in the maintenance phase of a schistosomiasis control programme in Saint Lucia, after chemotherapy. Bull World Health Organ 60(4):583–588
Kardorff R, Dohring E (2001) Ultrasound diagnosis of bilharziasis. Ultraschall Med 22(3):107–115
Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14(6):397–400
Keenan JD, Hotez PJ, Amza A, Stoller NE, Gaynor BD et al (2013) Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts. PLoS Negl Trop Dis 7(12):e2562
King CH, Bertino A-M (2008) Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 2(3):1–10
King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chron Illn 4(1):65–79
King CH, Keating CE, Muruka JF, Ouma JH, Houser H et al (1988) Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province. Kenya Am J Trop Med Hyg 39(4):361–368
King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365(9470):1561–1569
Kinkel HF, Dittrich S, Bäumer B, Weitzel T (2012) Evaluation of eight serological tests for diagnosis of imported schistosomiasis. Clin Vaccine Immunol 19(6):948–953
Le WJ, You JQ, Yang YQ, Mei JY, Guo HF, Yang HZ et al (1982) Studies on the efficacy of artemether in experimental schistosomiasis. YaoXue Xue Bao 17(3):187–193
Le WJ, You JQ, Mei JY (1983) Chemotherapeutic effect of artesunate in experimental schistosomiasis. YaoXue Xue Bao 18(8):619–621
Legesse M, Erko B (2007) Field-based evaluation of a reagent strip test for diagnosis of Schistosoma mansoni by detecting circulating cathodic antigen in urine before and after chemotherapy. Trans R Soc Trop Med Hyg 101(7):668–673
Legesse M, Erko B (2008) Field-based evaluation of a reagent strip test for diagnosis of schistosomiasis mansoni by detecting circulating cathodic antigen (CCA) in urine in low endemic area in Ethiopia. Parasite 15(2):151–155
Lengeler C, Utzinger J, Tanner M (2002) Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ. 80(3):235–42
Linehan M, Hanson C, Weaver A, Baker M, Kabore A et al (2011) Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale. Am J Trop Med Hyg 84(1):5–14
Liu R, Dong HF, Guo Y, Zhao QP, Jiang MS (2011) Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasitol Vectors 4:201. doi:10.1186/1756-3305-4-201
Lorenz W, Henglein A, Schrader G (1955) The new insecticide 0.0-dimethyl-2,2,2-trichloro-1-hydroxyethyl phosphate. J Am Chem Soc 77:2554
Manderson L, Aagaard-Hansen J, Allotey P, Gyapong M, Sommerfeld J (2009) Social research on neglected diseases of poverty: continuing and emerging themes. PLoS Negl Trop Dis 3:e332. doi:10.1371/journal.pntd.0000332
Mascie-Taylor CGN, Karim R, Karim E, Akhtar S, Ahmed T et al (2003) The cost-effectiveness of health education in improving knowledge and awareness about intestinal parasites in rural Bangladesh. Econ Hum Biol 1(3):321–330
Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, Downs JA (2011) Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 5(12):e1396. doi:10.1371/journal.pntd.0001396
McCoy D, Kembhavi G, Patel J, Luintel A (2009) The Bill & Melinda Gates Foundation’s grant-making programme for global health. Lancet 373:1645–1653
Minamoto K, Mascie-Taylor CGN, Karim E, Moji K, Rahman M (2012) Short- and long-term impact of health education in improving water supply, sanitation and knowledge about intestinal helminths in rural Bangladesh. Public Health 126(5):437–440
Mitchell KM, Mutapi F, Woolhouse ME (2008) The predicted impact of immunosuppression upon population age- intensity profiles for schistosomiasis. Parasite Immunol 30(9):462–470
Mott KE, Dixon H, Osei-Tutu E, England EC (1983) Relation between intensity of Schistosoma haematobium infection and clinical haematuria and proteinuria. Lancet 1(8332):1005–1008
Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX et al (2007) Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol 25(3):285–295
Ochodo EA, Spek B, Reitsma JB, Van Lieshout L, Polman K et al (2012) Rapid screening and diagnostic tests for human schistosomiasis in endemic areas. Cochrane Database Syst Rev (2):CD009579. doi:10.1002/14651858.CD009579
Odogwu SE, Ramamurthy NK, Kabatereine NB, Kazibwe F, Tukahebwa E, Webster JP, Fenwick A, Stothard JR (2006) Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 100(4):315–326
Olds GR, Dasarathy S (2000) Schistosomiasis. Curr Treat Options Infect Dis 2:88–99
Olsen A (2007) Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans R Soc Trop Med Hyg 101(8):747–758
Poda JN, Wango SP, Sorgho H, Dianou D (2004) Recent evolution of schistosomiasis in the water project of Sourou in Burkina Faso. Bull Soc Pathol Exot 97(1):15–18
Poggensee G, Feldmeier H (2001) Female genital schistosomiasis: facts and hypotheses. Acta Trop 79(3):193–210
Polman K, Stelma FF, De Vlas SJ, Sow S, Fathers L et al (2001) Dynamics of egg counts and circulating antigen levels in a recent Schistosoma mansoni focus in northern Senegal. Trop Med Int Health 6:538–544
Polman K, Stelma FF, Le Cessie S, De Vlas SJ, Falcao-Ferreira ST et al (2002) B. Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen. Ann Trop Med Parasitol 96:679–689
Rabello AL (1992) Parasitological diagnosis of schistosomiasis mansoni: faecal examination and rectal biopsy. Mem Inst Oswaldo Cruz 87(Suppl 4):325–331
Raso G, Utzinger J, Silué KD, Ouattara M, Yapi A et al (2005) Disparities in parasitic infections, perceived ill health and access to health care among poorer and less poor schoolchildren of rural Côte d’Ivoire. Trop Med Int Health 10:42–57
Reich MR, Fenwick A (2001) Schistosoma haematobium. N Engl J Med 344(15):1170
Renganathan E, Cioli D (1998) An international initiative on praziquantel use. Parasitol Today 14(10):390–391
Richter J (2003) The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 86(2–3):161–183
Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61:294–303
Salehe FS, Hassan SN (2012) Socio-economic effects of Schistosomiasis on. Irrigation rice growers in Morogoro, Tanzania. J Exp Agric 2(3):395–406
Sandoval N, Siles-Lucas M, Pérez-Arellano JL, Carranza C, Puente S et al (2006) A new PCR-based approach for the specific amplification of DNA from different Schistosoma species applicable to human urine samples. Parasitology 133(Pt 5):581–587
Schwartz E, Kozarsky P, Wilson M, Cetron M (2005) Schistosome infection among river rafters on Omo River Ethiopia. J Travel Med 12:3–8
Shekhar KC (1991) Schistosomiasis drug therapy and treatment considerations. Drugs 42(3):379–405
Shiff CJ, de Clarke V, Evans AC, Barnish G (1973) Molluscicide for the control of schistosomiasis in irrigation schemes. A study in Southern Rhodesia. Bull World Health Organ 48:299–307
Singer BH, Castro MC (2007) Bridges to sustainable tropical health. Proc Natl Acad Sci U S A 104:16038–16043
Snellen WM (1981) Therapeutic properties of metrifonate. Acta Pharmacol Toxicol (Copenh) 49(Suppl V 5):114–117
Spiegel JM, Dharamsi S, Wasan KM, Yassi A, Singer B, Hotez PJ et al (2010) Which new approaches to tackling neglected tropical diseases show promise? PLoS Med 7(5):e1000255. doi:10.1371/journal.pmed.1000255
Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425
Stelma FF, Talla I, Sow S, Kongs A, Niang M et al (1995) Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. Am J Trop Med Hyg 53:167–170
Stothard JR, Gabrielli AF (2007) Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 23:83–86
Stothard JR, Sousa-Figueiredo JC, Navaratnam AM (2013) Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis. Expert Rev Anti-Infect Ther 11(7):733–752
Striebel HP (1976) 4-Isothiocyanato-4′-nitrodiphenylamine (C 9333-Go/CGP 4540), an anthelminthic with an unusual spectrum of activity against intestinal nematodes, filariae and schistosomes. Experientia 32(4):457–458
Sturrock RF (2001) Schistosomiasis epidemiology and control: how did we get here and where should we go? Mem Inst Oswaldo Cruz 96(Suppl):17–27
Umeh JC, Amali O, Umeh EU (2004) The socio-economic effects of tropical diseases in Nigeria. Econ Hum Biol 2:245–263
Utzinger J, Keiser J (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5(2):263–285
Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH (2003a) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47:1487–1495
Utzinger J, Bergquist R, Xiao SH, Singer BH, Tanner M (2003b) Sustainable schistosomiasis control – the way forward. Lancet 362:1932–1934
Utzinger J, Xiao SH, Tanner M, Keiser J (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Invest Drugs 8(2):105–116
Utzinger J, Raso G, Brooker S, De Savigny D, Tanner M et al (2009) Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 136(13):1859–1874
Utzinger J, N’goran EK, Caffrey CR, Keiser J (2010) From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120 Suppl 1:S121–37
Utzinger J, N’goran EK, Caffrey CR, Keiser J (2011) From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120(Suppl 1):S121–S137
Valencia CI, Catto BA, Webster LT Jr, Barcelon E, Ofendo-Reyes R (1994) Concentration time course of praziquantel in Filipinos with mild Schistosoma japonicum infection. Southeast Asian J Trop Med Public Health 25(2):409–414
van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD et al (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86(2–3):125–139
Warren KS (1982) Schistosomiasis: host-pathogen biology. Infect Dis 4(4):771–775
Whitfield PJ, Bartlett A, Khammo N, Clothier RH (2003) Age-dependent survival and infectivity of Schistosoma mansoni cercariae. Parasitology 127(Pt 1):29–35
WHO (1985) The control of Schistosomiasis: report of WHO expert committee. Technical Report Series No. 728, Geneva
WHO (1998) Report of the WHO Informal Consultation on schistosomiasis control, Geneva 2–4 Dec, 1–44
WHO (2002a) Death and DALY estimates for 2004 by cause for WHO Member States: persons, all ages. World Health Organization. Retrieved 2009-11-12
WHO (2002b) Prevention and control of schistosomiasis and soil-transmitted helminthiasis, Geneva, World Health Organization, (WHO Technical Report Series, No. 912):1–57
WHO (2006a) Preventive chemotherapy in human helminthiasis. World Health Organization, Geneva, Also available from http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf
WHO (2006b) Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. World Health Organization, Geneva
WHO (2010a) Schistosomiasis, Fact Sheet No 115; February. World Health Organization Available at http://www.who.int/mediacentre/facesheets/fs115/en/index.html. Accessed 5 Oct 2010
WHO (2010b) Report of a Meeting to Review the Results of Studies on the treatment of Schistosomiasis in Preschool age Children, Geneva, 13–14 Sept. WHO/HTM/NTD/PCT/2011.7
WHO (2011) Report of an informal Consultation on schistosomiasis control, Geneva, 30 March – 1 April 2011
WHO (2012) Schistosomiasis: progress report 2001–2011 and strategic plan 2012–2020. World Health Organization, 1–82
WHO. World Health Organization (1993) The control of schistosomiasis. Second report of the WHO Expert Committee. WHO Tech Rep Ser 830:1–86
WHO. World Health Organization (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee. WHO Tech Rep Ser 912:1–57
Wikman-Jorgensen PE, Henríquez-Camacho CA, Serrano-Villar S, Pérez-Molina JA (2012) The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis. Pathog Glob Health 106(7):397–404
Wolfe MS, Quansah FO, Agbemadzo F (1966) Suppressive management of urinary schistosomiasis with antimony dimercaptosuccinate (TWSb) in Ghana. J Trop Med Hyg 69(10):217–223
Woolhouse M, Taylor P, Matanhire D, Chandiwana SK (1991) Acquired immunity and epidemiology of Schistosoma haematobium. Nature 351:757–759
Wright WH (1972) A consideration of economic impact of schistosomiasis. Bull World Health Organ 47(5):559–565
Wu GY, Halim MH (2000) Schistosomiasis: progress and problems. World J Gastroenterol 6(1):12–19
Zuidema PJ (1981) The Katayama syndrome: an outbreak in Dutch tourists to the Omo National Park. Ethiopia Trop Geogr Med 33:30–35
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Danso-Appiah, T. (2016). Schistosomiasis. In: Gyapong, J., Boatin, B. (eds) Neglected Tropical Diseases - Sub-Saharan Africa. Neglected Tropical Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-25471-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-25471-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25469-2
Online ISBN: 978-3-319-25471-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)